The ESMO Deep Dive - Lower Digestive Cancers Webinar Series recordings and slides are available to all ESMO Members.
ESMO Deep Dive: Lower Digestive Cancers - Molecular Selection and Monitoring of Adjuvant Strategies for Patients with Colorectal Cancer: Tissue, Liquid and Combos 2023
It is with great pleasure that I invite you to participate in the ESMO webinar on Deep Dive into Lower Digestive Cancers that will elaborate the molecular selection and monitoring of adjuvant strategies for patients with colorectal cancer: tissue, liquid and combos.
This webinar is developed with the aim to acquire a deeper understanding of the clinical course of malignant disease of the lower digestive system and understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for lower digestive cancers. Furthermore, the programme will enhance development of skills and abilities for critical analysis,
interpretation of research data and therapeutic strategies, as well as becoming better equipped for informed, innovative thinking and engagement in ongoing or new research projects.
I am delighted to announce the distinguished speakers who will join me in this webinar. We will begin with a lecture on current knowledge in molecular selection and monitoring of adjuvant strategies for patients with colorectal cancer and setting up the scene in 2023. Then we will cover a research glimpse in the ctDNA-driven future of managing localised colon cancer. Furthermore, we will elaborate research insights from neoadjuvant approaches across molecular subgroups of localised CRC. The lectures will be followed by live discussion by speaker’s panel.
The programme is designed to provide an overview of the state of the art and ongoing research in tissue and liquid biopsies for molecular selection and monitoring of adjuvant treatment, also covering combos. It will offer expert opinion exchange and provide some important considerations for practice and research in this field. I strongly encourage and invite you to register and join us all in this new ESMO activity.
Prof. Julien Taieb
Georges Pompidou European Hospital, Université de Paris, Paris, France
Speakers
Programme
Time |
Title |
Speaker |
---|---|---|
5 min |
Welcome and Introduction |
Julien Taieb |
25 min |
Current knowledge: setting up the scene in 2023 |
Sharlene Gill |
25 min |
A research glimpse in the ctDNA-driven future of managing localised colon cancer |
Jeanne Tie |
25 min |
Research insights from neoadjuvant approaches across molecular subgroups of localised colorectal cancer |
Jenny Seligmann |
15 min |
LIVE Q&A |
All |
A certificate of attendance and 2 ESMO-MORA category 1 points will be awarded for live attendance at this event
Learning objectives:
- To acquire a deeper understanding of the clinical course of malignant disease of the lower digestive system
- To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for Lower Digestive Cancers
- To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies
- To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects